Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
new york blog main
5
×
new york top stories
startups
5
×
national top stories
boston
deals
fda
investing
san francisco blog main
san francisco top stories
asklepios biopharmaceutical
biogen
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
novartis
ptc therapeutics
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
What
new
5
×
drugs
medicines
aims
bio
called
developing
research
roundup
absorb
activity
address
approach
approvals
backed
bails
based
biogen
biotech
body
brain
brand
bridgebio
builds
capital
car
cause
ceo
cerevasc
clamped
covid
debuts
delays
develop
device
drain
economic
emerges
epigenetic
epigenetics
Language
unset
5
×
Current search:
startups
×
unset
×
new
×
" new york blog main "
×
@xconomy.com
4 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further